Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,150.81
(
-0.06%
)
News Focus
News Focus
Post# of 517711
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Dr.Oph

Send PM Follow Ignore
Followers 5
Posts 17
Boards Moderated 0
Alias Born 12/28/2022

Dr.Oph

Re: georgejjl post# 508749

Monday, 11/17/2025 7:10:41 PM

Monday, November 17, 2025 7:10:41 PM

Post# of 517711
Within the limited scope of approval, i.e., ABCLEAR1, confirmation of clinical efficacy and biomarkers is essential for approval.
However, although the ITT results were announced, the AB1 results were missing.
Of course, we can speculate.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News